Paper41009877
Epidemiological Trends of Carbapenemase-Producing Pseudomonas aeruginosa in a Tertiary Care Hospital in Athens, Greece, During 2020-2023.
Koumaki V and 6 others. Antibiotics (Basel), 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Epidemiological Trends of Carbapenemase-Producing Pseudomonas aeruginosa in a Tertiary Care Hospital in Athens, Greece, During 2020-2023. Papers, record 41009877. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41009877
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Epidemiological Trends of Carbapenemase-Producing Pseudomonas aeruginosa in a Tertiary Care Hospital in Athens, Greece, During 2020-2023.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References28
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36568831 | The Intriguing Carbapenemases of Pseudomonas aeruginosa: Current Status, Genetic Profile, and Global Epidemiology. | Yale J Biol Med | 2022 | https://conductscience.org/library/papers/36568831 | PubMed |
| 2 | 19797945 | Colistin in the 21st century. | Curr Opin Infect Dis | 2009 | https://conductscience.org/library/papers/19797945 | PubMed |
| 3 | 32875545 | Treatment options for K. pneumoniae, P. aeruginosa and A. baumannii co-resistant to carbapenems, aminoglycosides, polymyxins and tigecycline: an approach based on the mechanisms of resistance to carbapenems. | Infection | 2020 | https://conductscience.org/library/papers/32875545 | PubMed |
| 4 | 24168643 | Carbapenemase-producing Pseudomonas aeruginosa from central Greece: molecular epidemiology and genetic analysis of class I integrons. | BMC Infect Dis | 2013 | https://conductscience.org/library/papers/24168643 | PubMed |
| 5 | 38530465 | Multidrug-resistant organism bloodstream infection and hospital acquisition among inpatients in three tertiary Greek hospitals during the COVID-19 era. | Eur J Clin Microbiol Infect Dis | 2024 | https://conductscience.org/library/papers/38530465 | PubMed |
| 6 | 38352089 | Cefiderocol (Fetroja) as a Treatment for Hospital-Acquired Pneumonia. | Cureus | 2024 | https://conductscience.org/library/papers/38352089 | PubMed |
| 7 | 29872449 | How to manage Pseudomonas aeruginosa infections. | Drugs Context | 2018 | https://conductscience.org/library/papers/29872449 | PubMed |
| 8 | 36774938 | Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort study. | Lancet Microbe | 2023 | https://conductscience.org/library/papers/36774938 | PubMed |
| 9 | 31492517 | Antibiotic resistance in Pseudomonas aeruginosa - Mechanisms, epidemiology and evolution. | Drug Resist Updat | 2019 | https://conductscience.org/library/papers/31492517 | PubMed |
| 10 | 35240944 | Carbapenemase-producing Pseudomonas aeruginosa -an emerging challenge. | Emerg Microbes Infect | 2022 | https://conductscience.org/library/papers/35240944 | PubMed |
| 11 | 34126951 | Burden of illness in US hospitals due to carbapenem-resistant Gram-negative urinary tract infections in patients with or without bacteraemia. | BMC Infect Dis | 2021 | https://conductscience.org/library/papers/34126951 | PubMed |
| 12 | 27573251 | Colistin: still a lifesaver for the 21st century? | Expert Opin Drug Metab Toxicol | 2017 | https://conductscience.org/library/papers/27573251 | PubMed |
| 13 | 23935307 | Mechanisms responsible for the emergence of carbapenem resistance in Pseudomonas aeruginosa. | Hippokratia | 2012 | https://conductscience.org/library/papers/23935307 | PubMed |
| 14 | 30895216 | Geographic and Temporal Patterns of Antimicrobial Resistance in Pseudomonas aeruginosa Over 20 Years From the SENTRY Antimicrobial Surveillance Program, 1997-2016. | Open Forum Infect Dis | 2019 | https://conductscience.org/library/papers/30895216 | PubMed |
| 15 | 38534720 | Antimicrobial and Diagnostic Stewardship of the Novel β-Lactam/β-Lactamase Inhibitors for Infections Due to Carbapenem-Resistant Enterobacterales Species and Pseudomonas aeruginosa. | Antibiotics (Basel) | 2024 | https://conductscience.org/library/papers/38534720 | PubMed |
| 16 | 34860333 | Aminoglycoside or Polymyxin Monotherapy for Treating Complicated Urinary Tract Infections Caused by Extensively Drug-Resistant Pseudomonas aeruginosa: A Propensity Score-Adjusted and Matched Cohort Study. | Infect Dis Ther | 2022 | https://conductscience.org/library/papers/34860333 | PubMed |
| 17 | 39200062 | Rapid Reversal of Carbapenemase-Producing Pseudomonas aeruginosa Epidemiology from blaVIM- to blaNDM-harbouring Isolates in a Greek Tertiary Care Hospital. | Antibiotics (Basel) | 2024 | https://conductscience.org/library/papers/39200062 | PubMed |
| 18 | 37764003 | First Detection and Molecular Characterization of Pseudomonas aeruginosa blaNDM-1 ST308 in Greece. | Microorganisms | 2023 | https://conductscience.org/library/papers/37764003 | PubMed |
| 19 | 10699045 | Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece. | J Clin Microbiol | 2000 | https://conductscience.org/library/papers/10699045 | PubMed |
| 20 | 33260774 | Unravelling the Features of Success of VIM-Producing ST111 and ST235 Pseudomonas aeruginosa in a Greek Hospital. | Microorganisms | 2020 | https://conductscience.org/library/papers/33260774 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42795678 | Multidrug-Resistant Bloodstream Infections Before and After COVID-19: A Temporal Assessment of Outcomes and Resistance Across Two Eras in a Non-COVID Intensive Care Unit-The MATURATE ICU Study. | Microorganisms | 2026 | https://conductscience.org/library/papers/42795678 |
Source PubMed
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| VIM | 7431 | PubTator's text mining | https://conductscience.org/library/genes/7431 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41009877
GET https://conductscience.org/api/papers/v1/41009877/references?page=2